These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35868306)

  • 1. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
    Bottomly D; Long N; Schultz AR; Kurtz SE; Tognon CE; Johnson K; Abel M; Agarwal A; Avaylon S; Benton E; Blucher A; Borate U; Braun TP; Brown J; Bryant J; Burke R; Carlos A; Chang BH; Cho HJ; Christy S; Coblentz C; Cohen AM; d'Almeida A; Cook R; Danilov A; Dao KT; Degnin M; Dibb J; Eide CA; English I; Hagler S; Harrelson H; Henson R; Ho H; Joshi SK; Junio B; Kaempf A; Kosaka Y; Laderas T; Lawhead M; Lee H; Leonard JT; Lin C; Lind EF; Liu SQ; Lo P; Loriaux MM; Luty S; Maxson JE; Macey T; Martinez J; Minnier J; Monteblanco A; Mori M; Morrow Q; Nelson D; Ramsdill J; Rofelty A; Rogers A; Romine KA; Ryabinin P; Saultz JN; Sampson DA; Savage SL; Schuff R; Searles R; Smith RL; Spurgeon SE; Sweeney T; Swords RT; Thapa A; Thiel-Klare K; Traer E; Wagner J; Wilmot B; Wolf J; Wu G; Yates A; Zhang H; Cogle CR; Collins RH; Deininger MW; Hourigan CS; Jordan CT; Lin TL; Martinez ME; Pallapati RR; Pollyea DA; Pomicter AD; Watts JM; Weir SJ; Druker BJ; McWeeney SK; Tyner JW
    Cancer Cell; 2022 Aug; 40(8):850-864.e9. PubMed ID: 35868306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Performing integrative transcriptomic and chemical screening to identify patient-specific vulnerabilities in poor-prognosis acute myeloid leukemia].
    Hashimoto M; Ishikawa F
    Rinsho Ketsueki; 2021; 62(7):774-780. PubMed ID: 34349062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
    Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
    Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia.
    Ng SWK; Murphy T; King I; Zhang T; Mah M; Lu Z; Stickle N; Ibrahimova N; Arruda A; Mitchell A; Mai M; He R; Madala BS; Viswanatha DS; Dick JE; Chan S; Virtanen C; Minden MD; Mercer T; Stockley T; Wang JCY
    Blood Adv; 2022 Feb; 6(3):1064-1073. PubMed ID: 34872104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
    Shi H; Gao L; Zhang W; Jiang M
    BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular hierarchies predict drug response in acute myeloid leukemia.
    Raffel S; Velten L; Haas S
    Cancer Cell; 2022 Sep; 40(9):917-919. PubMed ID: 36055227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
    Dembitz V; Lalic H; Kodvanj I; Tomic B; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    BMC Cancer; 2020 Nov; 20(1):1090. PubMed ID: 33176741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
    Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia.
    Docking TR; Parker JDK; Jädersten M; Duns G; Chang L; Jiang J; Pilsworth JA; Swanson LA; Chan SK; Chiu R; Nip KM; Mar S; Mo A; Wang X; Martinez-Høyer S; Stubbins RJ; Mungall KL; Mungall AJ; Moore RA; Jones SJM; Birol İ; Marra MA; Hogge D; Karsan A
    Nat Commun; 2021 Apr; 12(1):2474. PubMed ID: 33931648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
    Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
    JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 17-gene stemness score for rapid determination of risk in acute leukaemia.
    Ng SW; Mitchell A; Kennedy JA; Chen WC; McLeod J; Ibrahimova N; Arruda A; Popescu A; Gupta V; Schimmer AD; Schuh AC; Yee KW; Bullinger L; Herold T; Görlich D; Büchner T; Hiddemann W; Berdel WE; Wörmann B; Cheok M; Preudhomme C; Dombret H; Metzeler K; Buske C; Löwenberg B; Valk PJ; Zandstra PW; Minden MD; Dick JE; Wang JC
    Nature; 2016 Dec; 540(7633):433-437. PubMed ID: 27926740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia.
    Kolesnikova MA; Sen'kova AV; Pospelova TI; Zenkova MA
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1362. PubMed ID: 33675187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.
    Abadir E; Gasiorowski RE; Lai K; Kupresanin F; Romano A; Silveira PA; Lo TH; Fromm PD; Kennerson ML; Iland HJ; Ho PJ; Hogarth PM; Bradstock K; Hart DNJ; Clark GJ
    Mol Oncol; 2019 Oct; 13(10):2107-2120. PubMed ID: 31338922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.
    Fan H; Wang F; Zeng A; Murison A; Tomczak K; Hao D; Jelloul FZ; Wang B; Barrodia P; Liang S; Chen K; Wang L; Zhao Z; Rai K; Jain AK; Dick J; Daver N; Futreal A; Abbas HA
    Commun Biol; 2023 Jul; 6(1):765. PubMed ID: 37479893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.
    Ngo S; Oxley EP; Ghisi M; Garwood MM; McKenzie MD; Mitchell HL; Kanellakis P; Susanto O; Hickey MJ; Perkins AC; Kile BT; Dickins RA
    Nat Commun; 2021 Nov; 12(1):6546. PubMed ID: 34764270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
    Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
    J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision Medicine.
    Wang H; Chan KYY; Cheng CK; Ng MHL; Lee PY; Cheng FWT; Lam GKS; Chow TW; Ha SY; Chiang AKS; Leung WH; Leung AYH; Wang CC; Zhang T; Zhang XB; So CC; Yuen YP; Sun Q; Zhang C; Xu Y; Cheung JTK; Ng WH; Tang PM; Kang W; To KF; Lee WYW; Wong RSM; Poon ENY; Zhao Q; Huang J; Chen C; Yuen PMP; Li CK; Leung AWK; Leung KT
    Blood Cancer Discov; 2022 Nov; 3(6):516-535. PubMed ID: 35960210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
    Lim INX; Nagree MS; Xie SZ
    Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.
    Chen YK; Hou HA; Tang JL; Jhuang JY; Lai YJ; Lee MC; Kuo YY; Chou WC; Liu CY; Lin CW; Chuang SS; Chen CY; Tseng MH; Huang CF; Chiang YC; Lee FY; Liu MC; Liu CW; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    PLoS One; 2015; 10(3):e0119831. PubMed ID: 25794001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.